Abstract
The extracellular matrix (ECM) plays diverse roles in several physiological and pathological conditions. In the brain, the ECM is unique both in its composition and in functions. Furthermore, almost all the cells in the central nervous system contribute to different aspects of this intricate structure. Brain ECM, enriched with proteoglycans and other small proteins, aggregate into distinct structures around neurons and oligodendrocytes. These special structures have cardinal functions in the normal functioning of the brain, such as learning, memory, and synapse regulation. In this review, we have compiled the current knowledge about the structure and function of important ECM molecules in the brain and their proteolytic remodeling by matrix metalloproteinases and other enzymes, highlighting the special structures they form. In particular, the proteoglycans in brain ECM, which are essential for several vital functions, are emphasized in detail.
Similar content being viewed by others
Abbreviations
- AMPAR:
-
α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor
- AP-1:
-
Activator protein 1
- ASD:
-
Autism spectrum disorders
- Bral:
-
Brain-specific hyaluronan-binding protein
- CAM:
-
Cell adhesion molecule
- Cbln:
-
Cerebellin
- CNS:
-
Central nervous system
- CREB:
-
cAMP-response element-binding
- CRP:
-
Complement regulatory protein
- CSPG:
-
Chondroitin sulfate proteoglycan
- DCC:
-
Deleted in colorectal cancer
- ECD:
-
Extracellular domain
- ECM:
-
Extracellular matrix
- GAG:
-
Glycosaminoglycan
- HA:
-
Hyaluronic acid
- HAPLN1:
-
Hyaluronan and proteoglycan link protein 1
- HAS:
-
Hyaluronan synthase
- HSPG:
-
Heparin sulfate proteoglycan
- LTD:
-
Long-term depression
- LTP:
-
Long-term potentiation
- L-VDCC:
-
l-type voltage-dependent Ca2+ channels
- MMP:
-
Matrix metalloproteinase
- NMDAR:
-
N-methyl-d-aspartate receptor
- Narp:
-
Neuronal activity-regulated pentraxin
- NF-186:
-
Neurofascin-186
- NGC:
-
Neuroglycan C
- NrCAM:
-
Neuron–glia-related cell adhesion molecule
- PNN:
-
Perineuronal net
- PSI:
-
Phosphacan short isoform
- PTR:
-
Proteoglycan tandem repeat
- RPTP:
-
Receptor-type protein-tyrosine phosphatase
- SGGL:
-
Sulfoglucuronyl glycolipid
- SNAP-25:
-
Synaptosomal nerve-associated protein 25
- TIMP:
-
Tissue inhibitor of MMPs
- TNC:
-
Tenascin-C
- TNR:
-
Tenascin-R
- tPA:
-
Tissue plasminogen activator
References
Theocharis AD, Skandalis SS, Gialeli C, Karamanos NK (2016) Extracellular matrix structure. Adv Drug Deliv Rev 97:4–27. https://doi.org/10.1016/j.addr.2015.11.001
Yue B (2014) Biology of the extracellular matrix: an overview. J Glaucoma 23:S20–S23. https://doi.org/10.1097/IJG.0000000000000108
Reichardt L (1991) Extracellular matrix molecules and their receptors: functions in neural development. Annu Rev Neurosci 14:531–570. https://doi.org/10.1146/annurev.neuro.14.1.531
Naba A, Clauser KR, Ding H et al (2016) The extracellular matrix: tools and insights for the “omics” era. Matrix Biol 49:10–24. https://doi.org/10.1016/j.matbio.2015.06.003
Mouw JK, Ou G, Weaver VM (2014) Extracellular matrix assembly: a multiscale deconstruction. Nat Rev Mol Cell Biol 15:771–785. https://doi.org/10.1038/nrm3902
Afratis NA, Nikitovic D, Multhaupt HAB et al (2017) Syndecans—key regulators of cell signaling and biological functions. FEBS J 284:27–41. https://doi.org/10.1111/febs.13940
O’Toole EA (2001) Extracellular matrix and keratinocyte migration. Clin Exp Dermatol 26:525–530
Pickup MW, Mouw JK, Weaver VM (2014) The extracellular matrix modulates the hallmarks of cancer. EMBO Rep 15(12):1243–1253. https://doi.org/10.15252/embr.201439246
Walker C, Mojares E, del Río Hernández A (2018) Role of extracellular matrix in development and cancer progression. Int J Mol Sci 19:3028. https://doi.org/10.3390/ijms19103028
Afratis N, Gialeli C, Nikitovic D et al (2012) Glycosaminoglycans: key players in cancer cell biology and treatment. FEBS J 279:1177–1197. https://doi.org/10.1111/j.1742-4658.2012.08529.x
Druso JE, Fischbach C (2018) Biophysical properties of extracellular matrix: linking obesity and cancer. Trends Cancer 4:271–273. https://doi.org/10.1016/j.trecan.2018.02.001
Urciuolo F, Garziano A, Imparato G et al (2016) Biophysical properties of dermal building-blocks affect extra cellular matrix assembly in 3D endogenous macrotissue. Biofabrication 8:015010. https://doi.org/10.1088/1758-5090/8/1/015010
Koláčná L, Bakešová J, Varga F et al (2007) Biochemical and biophysical aspects of collagen nanostructure in the extracellular matrix. Physiol Res 56:51–60
Bonnans C, Chou J, Werb Z (2014) Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol 15:786–801. https://doi.org/10.1038/nrm3904
Hubmacher D, Apte SS (2013) The biology of the extracellular matrix: novel insights. Curr Opin Rheumatol 25:65
Wolman M (1962) Symposium on the ground substance of the central nervous system. Introduction. World Neurol 3:97
Hess A (1953) The ground substance of the central nervous system revealed by histochemical staining. J Comp Neurol 98:69–91. https://doi.org/10.1002/cne.900980106
Lei Y, Han H, Yuan F et al (2017) The brain interstitial system: anatomy, modeling, in vivo measurement, and applications. Prog Neurobiol 157:230–246. https://doi.org/10.1016/j.pneurobio.2015.12.007
Zimmermann DR, Dours-Zimmermann MT (2008) Extracellular matrix of the central nervous system: from neglect to challenge. Histochem Cell Biol 130:635–653. https://doi.org/10.1007/s00418-008-0485-9
Cragg B (1979) Brain extracellular space fixed for electron microscopy. Neurosci Lett 15:301–306. https://doi.org/10.1016/0304-3940(79)96130-5
Rasband MN, Peles E (2016) The nodes of Ranvier: molecular assembly and maintenance. Cold Spring Harb Perspect Biol 8:1–16. https://doi.org/10.1101/cshperspect.a020495
Bandtlow CE, Zimmermann DR (2000) Proteoglycans in the developing brain: new conceptual insights for old proteins. Physiol Rev 80:1267–1290. https://doi.org/10.1152/physrev.2000.80.4.1267
Hook M, Kjellen L, Johansson S, Robinson J (1984) Cell-surface glycosaminoglycans. Annu Rev Biochem 53:847–869. https://doi.org/10.1146/annurev.bi.53.070184.004215
Schwartz NB, Domowicz MS (2018) Proteoglycans in brain development and pathogenesis. FEBS Lett. https://doi.org/10.1002/1873-3468.13026
Aono S, Oohira A (2006) Chondroitin sulfate proteoglycans in the brain. Adv Pharmacol 53:323–336. https://doi.org/10.1016/S1054-3589(05)53015-1
Galtrey CM, Fawcett JW (2007) The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system. Brain Res Rev 4:1–18. https://doi.org/10.1016/j.brainresrev.2006.09.006
Dyck SM, Karimi-Abdolrezaee S (2015) Chondroitin sulfate proteoglycans: key modulators in the developing and pathologic central nervous system. Exp Neurol 269:169–187. https://doi.org/10.1016/j.expneurol.2015.04.006
Pantazopoulos H, Woo TUW, Lim MP et al (2010) Extracellular matrix-glial abnormalities in the amygdala and entorhinal cortex of subjects diagnosed with schizophrenia. Arch Gen Psychiatry. https://doi.org/10.1001/archgenpsychiatry.2009.196
Berretta S (2012) Extracellular matrix abnormalities in schizophrenia. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2011.08.010
Bonneh-Barkay D, Wiley CA (2009) Brain extracellular matrix in neurodegeneration. Brain Pathol 19:573–585. https://doi.org/10.1111/j.1750-3639.2008.00195.x
Avram S, Shaposhnikov S, Buiu C, Mernea M (2014) Chondroitin sulfate proteoglycans: structure-function relationship with implication in neural development and brain disorders. Biomed Res Int. https://doi.org/10.1155/2014/642798
Brittis PA, Canning DR, Silver J (1992) Chondroitin sulfate as a regulator of neuronal patterning in the retina. Science. https://doi.org/10.1126/science.1738848
Laabs T, Carulli D, Geller HM, Fawcett JW (2005) Chondroitin sulfate proteoglycans in neural development and regeneration. Curr Opin Neurobiol 15:116–120. https://doi.org/10.1016/j.conb.2005.01.014
Sugahara K, Mikami T (2007) Chondroitin/dermatan sulfate in the central nervous system. Curr Opin Struct Biol 17:536–545
Celio MR, Spreafico R, De Biasi S, Vitellaro-Zuccarello L (1998) Perineuronal nets: past and present. Trends Neurosci 21:510–515. https://doi.org/10.1016/S0166-2236(98)01298-3
Kjellen L (2002) Proteoglycans: structures and interactions. Annu Rev Biochem. https://doi.org/10.1146/annurev.biochem.60.1.443
Silbert JE, Sugumaran G (2002) Biosynthesis of chondroitin/dermatan sulfate. IUBMB life (International Union Biochem Mol Biol Life) 54:177–186. https://doi.org/10.1080/15216540214923
Akita K, von Holst A, Furukawa Y et al (2008) Expression of multiple chondroitin/dermatan sulfotransferases in the neurogenic regions of the embryonic and adult central nervous system implies that complex chondroitin sulfates have a role in neural stem cell maintenance. Stem Cells 26:798–809. https://doi.org/10.1634/stemcells.2007-0448
Gama CI, Tully SE, Sotogaku N et al (2006) Sulfation patterns of glycosaminoglycans encode molecular recognition and activity. Nat Chem Biol 2:467–473. https://doi.org/10.1038/nchembio810
Sherman LS, Back SA (2008) A “GAG” reflex prevents repair of the damaged CNS. Trends Neurosci 31:44–52
Beller JA, Kulengowski B, Kobraei EM et al (2013) Comparison of sensory neuron growth cone and filopodial responses to structurally diverse aggrecan variants, in vitro. Exp Neurol 247:143–157. https://doi.org/10.1016/J.EXPNEUROL.2013.02.012
Miyata S, Nishimura Y, Hayashi N, Oohira A (2005) Construction of perineuronal net-like structure by cortical neurons in culture. Neuroscience 136:95–104. https://doi.org/10.1016/j.neuroscience.2005.07.031
Maeda N (2010) Structural variation of chondroitin sulfate and its roles in the central nervous system. Cent Nerv Syst Agents Med Chem 10:22–31. https://doi.org/10.2174/187152410790780136
Yamaguchi Y (2000) Lecticans: organizers of the brain extracellular matrix. Cell Mol Life Sci 57:276–289
Iozzo RV (1998) Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 67:609–652. https://doi.org/10.1146/annurev.biochem.67.1.609
Sandy JD, Flannery CR, Boynton RE, Neame PJ (1990) Isolation and characterization of disulfide-bonded peptides from the three globular domains of aggregating cartilage proteoglycan. J Biol Chem 265:21108–21113. https://doi.org/10.1109/CEIDP.1994.592029
Neame PJ, Christner JE, Baker JR (1987) Cartilage proteoglycan aggregates. The link protein and proteoglycan amino-terminal globular domains have similar structures. J Biol Chem 262:17768–17778
Yamaguchi Y (2000) Lecticans: organizers of the brain extracellular matrix. Cell Mol Life Sci 57:276–289. https://doi.org/10.1007/PL00000690
Binette F, Cravens J, Kahoussi B et al (1994) Link protein is ubiquitously expressed in non-cartilaginous tissues where it enhances and stabilizes the interaction of proteoglycans with hyaluronic acid. J Biol Chem 269:19116–19122
Faissner A (1997) The tenascin gene family in axon growth and guidance. Cell Tissue Res 290:331–341. https://doi.org/10.1007/s004410050938
Aspberg A, Binkert C, Ruoslahti E (1995) The versican C-type lectin domain recognizes the adhesion protein tenascin-R. Proc Natl Acad Sci USA 92:10590–10594
Aspberg A, Miura R, Bourdoulous S et al (1997) The C-type lectin domains of lecticans, a family of aggregating chondroitin sulfate proteoglycans, bind tenascin-R by protein-protein interactions independent of carbohydrate moiety. Proc Natl Acad Sci USA 94:10116–10121. https://doi.org/10.1073/pnas.94.19.10116
Hagihara K, Miura R, Kosaki R et al (1999) Immunohistochemical evidence for the brevican-tenascin-R interaction: colocalization in perineuronal nets suggests a physiological role for the interaction in the adult rat brain. J Comp Neurol 410:256–264. https://doi.org/10.1002/(SICI)1096-9861(19990726)410:2%3c256:AID-CNE7%3e3.0.CO;2-5
Ujita M, Shinomura T, Ito K et al (1994) Expression and binding activity of the carboxyl-terminal portion of the core protein of PG-M, a large chondroitin sulfate proteoglycan. J Biol Chem 269:27603–27609
Miura R, Aspberg A, Ethell IM et al (1999) The proteoglycan lectin domain binds sulfated cell surface glycolipids and promotes cell adhesion. J Biol Chem 274:11431–11438. https://doi.org/10.1074/jbc.274.16.11431
Jungalwala FB (1994) Expression and biological functions of sulfoglucuronyl glycolipids (SGGLs) in the nervous system—a review. Neurochem Res 19:945–957. https://doi.org/10.1007/BF00968704
Poduslo S, Miller K (1985) Levels of sulfatide synthesis distinguish oligodendroglia in different stages of maturation. Neurochem Res 10:1285–1297
Grumet M, Milev P, Sakurai T et al (1994) Interactions with tenascin and differential effects on cell adhesion of neurocan and phosphacan, two major chondroitin sulfate proteoglycans of nervous tissue. J Biol Chem 269:12142–12146
Grumet M, Flaccus A, Margolis RU (1993) Functional characterization of chondroitin sulfate proteoglycans of brain: interactions with neurons and neural cell adhesion molecules. Rockefeller University Press, New York
Rauch U, Clement A, Retzler C et al (1997) Mapping of a defined neurocan binding site to distinct domains of tenascin-C. J Biol Chem 272:26905–26912. https://doi.org/10.1074/jbc.272.43.26905
Friedlander DR, Milev P, Karthikeyan L et al (1994) The neuronal chondroitin sulfate proteoglycan neurocan binds to the neural cell adhesion molecules Ng-CAM/L1/NILE and N-CAM, and inhibits neuronal adhesion and neurite outgrowth. J Cell Biol 125:669–680. https://doi.org/10.1083/jcb.125.3.669
Milev P, Fischer D, Haring M et al (1997) The fibrinogen-like globe of tenascin-C mediates its interactions with neurocan and phosphacan/protein-tyrosine phosphatase-ζ/β. J Biol Chem 272:15501–15509. https://doi.org/10.1074/jbc.272.24.15501
Xu Y, Fisher GJ (2012) Receptor type protein tyrosine phosphatases (RPTPs)—roles in signal transduction and human disease. J. Cell Commun, Signal
Fischer EH, Charbonneau H, Tonks NK (1991) Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes. Science 253(80):401–406. https://doi.org/10.1126/science.1650499
Shitara K, Yamada H, Watanabe K et al (1994) Brain-specific receptor-type protein-tyrosine phosphatase RPTPβ is a chondroitin sulfate proteoglycan in vivo. J Biol Chem 269:20189–20193. https://doi.org/10.1111/bjc.12074
Krueger NX, Saito H (1992) A human transmembrane protein-tyrosine-phosphatase, PTP zeta, is expressed in brain and has an N-terminal receptor domain homologous to carbonic anhydrases. Proc Natl Acad Sci USA 89:7417–7421. https://doi.org/10.1073/pnas.89.16.7417
Maeda N, Noda M (1998) Involvement of receptor-like protein tyrosine phosphatase ζ/RPTPβ and its ligand pleiotrophin/heparin-binding growth-associated molecule (HB-GAM) in neuronal migration. J Cell Biol 142:203–216. https://doi.org/10.1083/jcb.142.1.203
Saito H (1993) Structural diversity of eukaryotic protein tyrosine phosphatases: functional and evolutionary implications. Semin Cell Dev Biol. https://doi.org/10.1006/scel.1993.1045
Milev P, Friedlander DR, Sakurai T et al (1994) Interactions of the chondroitin sulfate proteoglycan phosphacan, the extracellular domain of a receptor-type protein tyrosine phosphatase, with neurons, glia, and neural cell adhesion molecules. J Cell Biol 127:1703–1715. https://doi.org/10.1083/jcb.127.6.1703
Garwood J, Heck N, Reichardt F, Faissner A (2003) Phosphacan short isoform, a novel non-proteoglycan variant of phosphacan/receptor protein tyrosine phosphatase-β, interacts with neuronal receptors and promotes neurite outgrowth. J Biol Chem 278:24164–24173. https://doi.org/10.1074/jbc.M211721200
Peles E, Schlessinger J, Grumet M (1998) Multi-ligand interactions with receptor-like protein tyrosine phosphatase β: implications for intercellular signaling. Trends Biochem Sci 23:121–124. https://doi.org/10.1016/S0968-0004(98)01195-5
Ohyama K, Ikeda E, Kawamura K et al (2004) Receptor-like protein tyrosine phosphatase ζ/RPTP β is expressed on tangentially aligned neurons in early mouse neocortex. Dev Brain Res 148:121–127. https://doi.org/10.1016/j.devbrainres.2003.10.012
Hayashi N, Miyata S, Yamada M et al (2005) Neuronal expression of the chondroitin sulfate proteoglycans receptor-type protein-tyrosine phosphatase β and phosphacan. Neuroscience 131:331–348. https://doi.org/10.1016/j.neuroscience.2004.11.017
Dobbertin A, Rhodes KE, Garwood J et al (2003) Regulation of RPTPβ/phosphacan expression and glycosaminoglycan epitopes in injured brain and cytokine-treated glia. Mol Cell Neurosci 24:951–971. https://doi.org/10.1016/S1044-7431(03)00257-4
Chow JPH, Fujikawa A, Shimizu H et al (2008) Metalloproteinase- and γ-secretase-mediated cleavage of protein-tyrosine phosphatase receptor type Z. J Biol Chem. https://doi.org/10.1074/jbc.M802976200
Watanabe E, Maeda N, Matsui F et al (1995) Neuroglycan C, a novel membrane-spanning chondroitin sulfate proteoglycan that is restricted to the brain. J Biol Chem 270:26876–26882. https://doi.org/10.1074/jbc.270.45.26876
Yasuda Y, Tokita Y, Aono S et al (1998) Cloning and chromosomal mapping of the human gene of neuroglycan C (NGC), a neural transmembrane chondroitin sulfate proteoglycan with an EGF module. Neurosci Res 32:313–322. https://doi.org/10.1016/S0168-0102(98)00098-4
Aono S, Tokita Y, Yasuda Y et al (2006) Expression and identification of a new splice variant of neuroglycan C, a transmembrane chondroitin sulfate proteoglycan, in the human brain. J Neurosci Res 83:110–118. https://doi.org/10.2337/dc13-0560
Aono S, Keino H, Ono T et al (2000) Genomic organization and expression pattern of mouse neuroglycan C in the cerebellar development. J Biol Chem 275:337–342. https://doi.org/10.1074/jbc.275.1.337
Aono S, Tokita Y, Shuo T et al (2004) Glycosylation site for chondroitin sulfate on the neural part-time proteoglycan, neuroglycan C. J Biol Chem 279:46536–46541. https://doi.org/10.1074/jbc.M403263200
Kinugasa Y, Ishiguro H, Tokita Y et al (2004) Neuroglycan C, a novel member of the neuregulin family. Biochem Biophys Res Commun 321:1045–1049. https://doi.org/10.1016/j.bbrc.2004.07.066
Nakanishi K, Aono S, Hirano K et al (2006) Identification of neurite outgrowth-promoting domains of neuroglycan C, a brain-specific chondroitin sulfate proteoglycan, and involvement of phosphatidylinositol 3-kinase and protein kinase C signaling pathways in neuritogenesis. J Biol Chem. https://doi.org/10.1074/jbc.M601498200
Nörenberg U, Hubert M, Rathjen FG (1996) Structural and functional characterization of tenascin-R (restrictin), an extracellular matrix glycoprotein of glial cells and neurons. Int J Dev Neurosci 14:217–231. https://doi.org/10.1016/0736-5748(96)00009-3
Kammerer RA, Schulthess T, Landwehr R et al (1998) Tenascin-C hexabrachion assembly is a sequential two-step process initiated by coiled-coil α-helices. J Biol Chem 273:10602–10608. https://doi.org/10.1074/jbc.273.17.10602
Valcourt U, Alcaraz LB, Exposito JY et al (2015) Tenascin-X: beyond the architectural function. Cell Adhes Migr 9:154–165. https://doi.org/10.4161/19336918.2014.994893
Faissner A, Kruse J, Chiquet-Ehrismann R, Mackie E (1988) The high-molecular-weight J1 glycoproteins are immunochemically related to tenascin. Differentiation 37:104–114. https://doi.org/10.1111/j.1432-0436.1988.tb00802.x
Chiquet-Ehrismann R, Tucker RP (2011) Tenascins and the importance of adhesion modulation. Cold Spring Harb Perspect Biol 3:1–19. https://doi.org/10.1101/cshperspect.a004960
Tucker RP, Drabikowski K, Hess JF et al (2006) Phylogenetic analysis of the tenascin gene family: evidence of origin early in the chordate lineage. BMC Evol Biol 6:60. https://doi.org/10.1186/1471-2148-6-60
Götz B, Scholze A, Clement A et al (1996) Tenascin-C contains distinct adhesive, anti-adhesive, and neurite outgrowth promoting sites for neurons. J Cell Biol. https://doi.org/10.1083/jcb.132.4.681
Joester A, Faissner A (2001) The structure and function of tenascins in the nervous system. Matrix Biol 20:13–22. https://doi.org/10.1016/S0945-053X(00)00136-0
Pas J, Wyszko E, Rolle K et al (2006) Analysis of structure and function of tenascin-C. Int J Biochem Cell Biol 38:1594–1602. https://doi.org/10.1016/j.biocel.2006.03.017
Lundell A, Olin AI, Mörgelin M et al (2004) Structural basis for interactions between tenascins and lectican C-type lectin domains: evidence for a crosslinking role for tenascins. Structure 12:1495–1506. https://doi.org/10.1016/j.str.2004.05.021
Brückner G, Grosche J, Schmidt S et al (2000) Postnatal development of perineuronal nets in wild-type mice and in a mutant deficient in tenascin-R. J Comp Neurol 428:616–629. https://doi.org/10.1002/1096-9861(20001225)428:4%3c616:AID-CNE3%3e3.0.CO;2-K
Testa D, Prochiantz A, Di Nardo AA (2018) Perineuronal nets in brain physiology and disease. Semin Cell Dev Biol. https://doi.org/10.1016/j.semcdb.2018.09.011
Spicer AP, Joo A, Bowling RA (2003) A hyaluronan binding link protein gene family whose members are physically linked adjacent to chrondroitin sulfate proteoglycan core protein genes. The missing links. J Biol Chem 278:21083–21091. https://doi.org/10.1074/jbc.M213100200
Oohashi T, Edamatsu M, Bekku Y, Carulli D (2015) The hyaluronan and proteoglycan link proteins: organizers of the brain extracellular matrix and key molecules for neuronal function and plasticity. Exp Neurol 274:134–144. https://doi.org/10.1016/j.expneurol.2015.09.010
Bekku Y, Su WD, Hirakawa S et al (2003) Molecular cloning of Bral2, a novel brain-specific link protein, and immunohistochemical colocalization with brevican in perineuronal nets. Mol Cell Neurosci. https://doi.org/10.1016/S1044-7431(03)00133-7
Deepa SS, Carulli D, Galtrey C et al (2006) Composition of perineuronal net extracellular matrix in rat brain: a different disaccharide composition for the net-associated proteoglycans. J Biol Chem 281:17789–17800. https://doi.org/10.1074/jbc.M600544200
Dityatev A, Rusakov DA (2011) Molecular signals of plasticity at the tetrapartite synapse. Curr Opin Neurobiol 21:353–359. https://doi.org/10.1016/j.conb.2010.12.006
Carulli D, Pizzorusso T, Kwok JCF et al (2010) Animals lacking link protein have attenuated perineuronal nets and persistent plasticity. Brain 133:2331–2347. https://doi.org/10.1093/brain/awq145
Bekku Y, Saito M, Moser M et al (2012) Bral2 is indispensable for the proper localization of brevican and the structural integrity of the perineuronal net in the brainstem and cerebellum. J Comp Neurol 520:1721–1736. https://doi.org/10.1002/cne.23009
Bekku Y, Rauch U, Ninomiya Y, Oohashi T (2009) Brevican distinctively assembles extracellular components at the large diameter nodes of Ranvier in the CNS. J Neurochem 108:1266–1276. https://doi.org/10.1111/j.1471-4159.2009.05873.x
Bekku Y, Vargova L, Goto Y et al (2010) Bral1: its role in diffusion barrier formation and conduction velocity in the CNS. J Neurosci 30:3113–3123. https://doi.org/10.1523/JNEUROSCI.5598-09.2010
Oohashi T, Hirakawa S, Bekku Y et al (2002) Bral1, a brain-specific link protein, colocalizing with the versican V2 isoform at the nodes of Ranvier in developing and adult mouse central nervous systems. Mol Cell Neurosci. https://doi.org/10.1006/mcne.2001.1061
Brückner G, Brauer K, Härtig W et al (1993) Perineuronal nets provide a polyanionic, glia-associated form of microenvironment around certain neurons in many parts of the rat brain. Glia 8:183–200. https://doi.org/10.1002/glia.440080306
Itano N, Sawai T, Yoshida M et al (1999) Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem 274:25085–25092. https://doi.org/10.1074/jbc.274.35.25085
Kwok JCF, Carulli D, Fawcett JW (2010) In vitro modeling of perineuronal nets: hyaluronan synthase and link protein are necessary for their formation and integrity. J Neurochem 114:1447–1459. https://doi.org/10.1111/j.1471-4159.2010.06878.x
Carulli D, Rhodes KE, Brown DJ et al (2006) Composition of perineuronal nets in the adult rat cerebellum and the cellular origin of their components. J Comp Neurol 494:559–577. https://doi.org/10.1002/cne.20822
Golgi C (1893) Intorno all'origine del quarto nervo cerebrale (patetico o trocleare) e di una questione di Isto - fisiologia generale che a questo argomento si ricollega. Rend Mat Acc Lincei s. 5 2(1):379–389
Golgi C (1898) Intorno alla struttura delle cellule nervose. XXV. Sulla struttura delle cellule nervose dei ganglin spinali. Boll Soc Med Chirurgica di Pavia 1:655–665
Härtig W, Brauer K, Brückner G (1992) Wisteria floribunda agglutinin-labelled nets surround parvalbumin-containing neurons. NeuroReport. https://doi.org/10.1097/00001756-199210000-00012
Giamanco KAA, Matthews RTT (2012) Deconstructing the perineuronal net: cellular contributions and molecular composition of the neuronal extracellular matrix. Neuroscience 218:367–384. https://doi.org/10.1016/j.neuroscience.2012.05.055
Tsien RY (2013) Very long-term memories may be stored in the pattern of holes in the perineuronal net. Proc Natl Acad Sci. https://doi.org/10.1073/pnas.1310158110
Lorenzo Bozzelli P, Alaiyed S, Kim E et al (2018) Proteolytic remodeling of perineuronal nets: effects on synaptic plasticity and neuronal population dynamics. Neural Plast. https://doi.org/10.1155/2018/5735789
Sorg BA, Berretta S, Blacktop JM et al (2016) Casting a wide net: role of perineuronal nets in neural plasticity. J Neurosci. https://doi.org/10.1523/JNEUROSCI.2351-16.2016
Lasek AW, Chen H, Chen WY (2017) Releasing addiction memories trapped in perineuronal nets. Trends Genet 34:197–208. https://doi.org/10.1016/j.tig.2017.12.004
Morishita H, Hensch TK (2008) Critical period revisited: impact on vision. Curr Opin Neurobiol 18:101–107. https://doi.org/10.1016/j.conb.2008.05.009
Lorenzo Bozzelli P, Alaiyed S, Kim E et al (2018) Proteolytic remodeling of perineuronal nets: effects on synaptic plasticity and neuronal population dynamics. Neural Plast 2018:1–13. https://doi.org/10.1155/2018/5735789
Wen TH, Binder DK, Ethell IM, Razak KA (2018) The Perineuronal ‘Safety’ Net? Perineuronal net abnormalities in neurological disorders. Front Mol Neurosci. https://doi.org/10.3389/fnmol.2018.00270
Giamanco KA, Morawski M, Matthews RT (2010) Perineuronal net formation and structure in aggrecan knockout mice. Neuroscience 170:1314–1327. https://doi.org/10.1016/j.neuroscience.2010.08.032
Matthews RT, Kelly GM, Zerillo CA et al (2002) Aggrecan glycoforms contribute to the molecular heterogeneity of perineuronal nets. J Neurosci 22:7536–7547
Ruoslahti E (1996) Brain extracellular matrix. Glycobiology 6:489–492. https://doi.org/10.1093/glycob/6.5.489
Matsumoto K, Shionyu M, Go M et al (2003) Distinct interaction of versican/PG-M with hyaluronan and link protein. J Biol Chem 278:41205–41212. https://doi.org/10.1074/jbc.M305060200
Blundell CD, Almond A, Mahoney DJ et al (2005) Towards a structure for a TSG-6·hyaluronan complex by modeling and NMR, spectroscopy: insights into other members of the link module superfamily. J Biol Chem 280:18189–18201. https://doi.org/10.1074/jbc.M414343200
Seyfried NT, McVey GF, Almond A et al (2005) Expression and purification of functionally active hyaluronan-binding domains from human cartilage link protein, aggrecan and versican: formation of ternary complexes with defined hyaluronan oligosaccharides. J Biol Chem 280:5435–5448. https://doi.org/10.1074/jbc.M411297200
Rutka JT, Apodaca G, Stern R, Rosenblum M (1988) The extracellular matrix of the central and peripheral nervous systems: structure and function. J Neurosurg 69:155–170. https://doi.org/10.3171/jns.1988.69.2.0155
van’t Spijker HM, Kwok JCF (2017) A sweet talk: the molecular systems of perineuronal nets in controlling neuronal communication. Front Integr Neurosci. https://doi.org/10.3389/fnint.2017.00033
Karetko M, Skangiel-Kramska J (2009) Diverse functions of perineuronal nets. Acta Neurobiol Exp (Wars) 69:564–577
Pantazopoulos H, Berretta S (2016) In sickness and in health: perineuronal nets and synaptic plasticity in psychiatric disorders. Neural Plast 2016:9847696
Belichenko PV, Hagberg B, Dahlström A (1997) Morphological study of neocortical areas in Rett syndrome. Acta Neuropathol 93:50–61. https://doi.org/10.1007/s004010050582
Hensch TK (2005) Critical period plasticity in local cortical circuits. Nat Rev Neurosci 6:877–888
Sorg BA, Berretta S, Blacktop JM et al (2016) Casting a wide net: role of perineuronal nets in neural plasticity. J Neurosci 36:11459–11468. https://doi.org/10.1523/JNEUROSCI.2351-16.2016
Lensjø KK, Lepperød ME, Dick G et al (2017) Removal of perineuronal nets unlocks juvenile plasticity through network mechanisms of decreased inhibition and increased gamma activity. J Neurosci 37:1269–1283. https://doi.org/10.1523/JNEUROSCI.2504-16.2016
van’t Spijker HM, Kwok JCF (2017) A sweet talk: the molecular systems of perineuronal nets in controlling neuronal communication. Front Integr Neurosci 11:33. https://doi.org/10.3389/fnint.2017.00033
Frischknecht R, Heine M, Perrais D et al (2009) Brain extracellular matrix affects AMPA receptor lateral mobility and short-term synaptic plasticity. Nat Neurosci 12:897–904. https://doi.org/10.1038/nn.2338
Deepa SS, Umehara Y, Higashiyama S et al (2002) Specific molecular interactions of oversulfated chondroitin sulfate E with various heparin-binding growth factors: implications as a physiological binding partner in the brain and other tissues. J Biol Chem 277:43707–43716. https://doi.org/10.1074/jbc.M207105200
Caroni P, Donato F, Muller D (2012) Structural plasticity upon learning: regulation and functions. Nat Rev Neurosci 13:478–490
Tsien RY (2013) Very long-term memories may be stored in the pattern of holes in the perineuronal net. Proc Natl Acad Sci 110:12456–12461. https://doi.org/10.1073/pnas.1310158110
Cohen LD, Zuchman R, Sorokina O et al (2013) Metabolic turnover of synaptic proteins: kinetics, interdependencies and implications for synaptic maintenance. PLoS One 8:e63191. https://doi.org/10.1371/journal.pone.0063191
Happel MFK, Niekisch H, Castiblanco Rivera LL et al (2014) Enhanced cognitive flexibility in reversal learning induced by removal of the extracellular matrix in auditory cortex. Proc Natl Acad Sci 111:2800–2805. https://doi.org/10.1073/pnas.1310272111
Bradshaw KP, Figueroa Velez DX, Habeeb M, Gandhi SP (2018) Precocious deposition of perineuronal nets on Parvalbumin inhibitory neurons transplanted into adult visual cortex. Sci Rep 8:7480. https://doi.org/10.1038/s41598-018-25735-8
Wen TH, Afroz S, Reinhard SM et al (2017) Genetic reduction of matrix metalloproteinase-9 promotes formation of perineuronal nets around parvalbumin-expressing interneurons and normalizes auditory cortex responses in developing fmr1 knock-out mice. Cereb Cortex. https://doi.org/10.1093/cercor/bhx258
Cabungcal J-H, Steullet P, Morishita H et al (2013) Perineuronal nets protect fast-spiking interneurons against oxidative stress. Proc Natl Acad Sci 110:9130–9135. https://doi.org/10.1073/pnas.1300454110
Balmer TS (2016) Perineuronal nets enhance the excitability of fast-spiking neurons. eNeuro. https://doi.org/10.1523/ENEURO.0112-16.2016
Rossier J, Bernard A, Cabungcal JH et al (2015) Cortical fast-spiking parvalbumin interneurons enwrapped in the perineuronal net express the metallopeptidases Adamts8, Adamts15 and Neprilysin. Mol Psychiatry 20:154–161. https://doi.org/10.1038/mp.2014.162
Dupret D, Pleydell-Bouverie B, Csicsvari J (2008) Inhibitory interneurons and network oscillations. Proc Natl Acad Sci 105:18079–18080. https://doi.org/10.1073/pnas.0810064105
Engel AK, Fries P, Singer W (2001) Dynamic predictions: oscillations and synchrony in top–down processing. Nat Rev Neurosci 2:704–716. https://doi.org/10.1038/35094565
Howard MW, Rizzuto DS, Caplan JB et al (2003) Gamma oscillations correlate with working memory load in humans. Cereb Cortex 13:1369–1374
Sun ZY, Bozzelli PL, Caccavano A et al (2018) Disruption of perineuronal nets increases the frequency of sharp wave ripple events. Hippocampus 28:42–52. https://doi.org/10.1002/hipo.22804
Schüppel K, Brauer K, Härtig W et al (2002) Perineuronal nets of extracellular matrix around hippocampal interneurons resist destruction by activated microglia in trimethyltin-treated rats. Brain Res 958:448–453. https://doi.org/10.1016/S0006-8993(02)03569-2
Ferrer-Ferrer M, Dityatev A (2018) Shaping synapses by the neural extracellular matrix. Front Neuroanat 12:40. https://doi.org/10.3389/fnana.2018.00040
Eroglu C (2009) The role of astrocyte-secreted matricellular proteins in central nervous system development and function. J Cell Commun Signal 3:167–176
Christopherson KS, Ullian EM, Stokes CCA et al (2005) Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell 120:421–433. https://doi.org/10.1016/j.cell.2004.12.020
Xu J, Xiao N, Xia J (2010) Thrombospondin 1 accelerates synaptogenesis in hippocampal neurons through neuroligin 1. Nat Neurosci 13:22–24. https://doi.org/10.1038/nn.2459
Benton RL, Maddie MA, Worth CA et al (2008) Transcriptomic screening of microvascular endothelial cells implicates novel molecular regulators of vascular dysfunction after spinal cord injury. J Cereb Blood Flow Metab 28:1771–1785. https://doi.org/10.1038/jcbfm.2008.76
Lin T-N, Kim G-M, Chen J-J et al (2003) Differential regulation of thrombospondin-1 and thrombospondin-2 after focal cerebral ischemia/reperfusion. Stroke 34:177–186. https://doi.org/10.1161/01.STR.0000047100.84604.BA
Liauw J, Hoang S, Choi M et al (2008) Thrombospondins 1 and 2 are necessary for synaptic plasticity and functional recovery after stroke. J Cereb Blood Flow Metab 28:1722–1732. https://doi.org/10.1038/jcbfm.2008.65
Eroglu C, Allen NJ, Susman MW et al (2009) Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis. Cell 139:380–392. https://doi.org/10.1016/j.cell.2009.09.025
Favuzzi E, Marques-Smith A, Deogracias R et al (2017) Activity-dependent gating of parvalbumin interneuron function by the perineuronal net protein brevican. Neuron 95:639–655. https://doi.org/10.1016/J.NEURON.2017.06.028
Brakebusch C, Seidenbecher CI, Asztely F et al (2002) Brevican-deficient mice display impaired hippocampal CA1 long-term potentiation but show no obvious deficits in learning and memory. Mol Cell Biol 22:7417–7427. https://doi.org/10.1128/mcb.22.21.7417-7427.2002
Chang MC, Park JM, Pelkey KA et al (2010) Narp regulates homeostatic scaling of excitatory synapses on Parvalbumin interneurons. Nat Neurosci 13:1090–1097. https://doi.org/10.1038/nn.2621.Narp
Pelkey KA, Barksdale E, Craig MT et al (2015) Pentraxins coordinate excitatory synapse maturation and circuit integration of parvalbumin interneurons. Neuron 85:1257–1272. https://doi.org/10.1016/j.neuron.2015.02.020
Xiao MF, Xu D, Craig MT et al (2017) NPTX2 and cognitive dysfunction in Alzheimer’s Disease. Elife 6:1–27
Baudouin S, Scheiffele P (2010) SnapShot: neuroligin-neurexin complexes. Cell 141:908
Kucukdereli H, Allen NJ, Lee AT et al (2011) Control of excitatory CNS synaptogenesis by astrocyte-secreted proteins Hevin and SPARC. Proc Natl Acad Sci 108:E440–E449. https://doi.org/10.1073/pnas.1104977108
Wei P, Pattarini R, Rong Y et al (2012) The Cbln family of proteins interact with multiple signaling pathways. J Neurochem 121:717–729. https://doi.org/10.1111/j.1471-4159.2012.07648.x
Haddick PCG, Tom I, Luis E et al (2014) Defining the ligand specificity of the deleted in colorectal cancer (DCC) receptor. PLoS One 9:e84823. https://doi.org/10.1371/journal.pone.0084823
Rong Y, Wei P, Parris J et al (2012) Comparison of Cbln1 and Cbln2 functions using transgenic and knockout mice. J Neurochem 120:528–540. https://doi.org/10.1111/j.1471-4159.2011.07604.x
Hirai H, Pang Z, Bao D et al (2005) Cbln1 is essential for synaptic integrity and plasticity in the cerebellum. Nat Neurosci 8:1534–1541. https://doi.org/10.1038/nn1576
Kusnoor SV, Parris J, Muly EC et al (2010) Extracerebellar role for cerebellin 1: modulation of dendritic spine density and synapses in striatal medium spiny neurons. J Comp Neurol 518:2525–2537. https://doi.org/10.1002/cne.22350
Knight D, Xie W, Boulianne GL (2011) Neurexins and neuroligins: recent insights from invertebrates. Mol Neurobiol 44:426. https://doi.org/10.1007/S12035-011-8213-1
Bock HH, May P (2016) Canonical and non-canonical Reelin signaling. Front Cell Neurosci 10:166. https://doi.org/10.3389/fncel.2016.00166
Leemhuis J, Bouché E, Frotscher M et al (2010) Reelin signals through apolipoprotein E receptor 2 and Cdc42 to increase growth cone motility and filopodia formation. J Neurosci 30:14759–14772. https://doi.org/10.1523/JNEUROSCI.4036-10.2010
Lee GH, D’Arcangelo G (2016) New insights into Reelin-mediated signaling pathways. Front Cell Neurosci 10:122. https://doi.org/10.3389/fncel.2016.00122
Niu S, Renfro A, Quattrocchi CC et al (2004) Reelin promotes hippocampal dendrite development through the VLDLR/ApoER2-Dab1 pathway. Neuron 41:71–84. https://doi.org/10.1016/S0896-6273(03)00819-5
Niu S, Yabut O, D’Arcangelo G (2008) The Reelin signaling pathway promotes dendritic spine development in hippocampal neurons. J Neurosci 28:10339–10348. https://doi.org/10.1523/JNEUROSCI.1917-08.2008
Bosch C, Masachs N, Exposito-Alonso D et al (2016) Reelin regulates the maturation of dendritic spines, synaptogenesis and glial ensheathment of newborn granule cells. Cereb Cortex 26:4282–4298. https://doi.org/10.1093/cercor/bhw216
Lane-Donovan C, Philips GT, Herz J (2014) More than cholesterol transporters: lipoprotein receptors in CNS function and neurodegeneration. Neuron 83:771–787. https://doi.org/10.1016/J.NEURON.2014.08.005
Weeber EJ, Beffert U, Jones C et al (2002) Reelin and apoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. J Biol Chem 277:39944–39952. https://doi.org/10.1074/jbc.M205147200
Chen Y, Beffert U, Ertunc M et al (2005) Reelin modulates NMDA receptor activity in cortical neurons. J Neurosci 25:8209–8216. https://doi.org/10.1523/JNEUROSCI.1951-05.2005
Campo CG, Sinagra M, Verrier D et al (2009) Reelin secreted by GABAergic neurons regulates glutamate receptor homeostasis. PLoS One 4:e5505. https://doi.org/10.1371/journal.pone.0005505
Qiu S, Zhao LF, Korwek KM, Weeber EJ (2006) Differential reelin-induced enhancement of NMDA and AMPA receptor activity in the adult hippocampus. J Neurosci 26:12943–12955. https://doi.org/10.1523/JNEUROSCI.2561-06.2006
Knuesel I (2010) Reelin-mediated signaling in neuropsychiatric and neurodegenerative diseases. Prog Neurobiol 91:257–274
Folsom TD, Fatemi SH (2013) The involvement of Reelin in neurodevelopmental disorders. Neuropharmacology 68:122–135
Oohashi T, Edamatsu M, Bekku Y, Carulli D (2015) The hyaluronan and proteoglycan link proteins: organizers of the brain extracellular matrix and key molecules for neuronal function and plasticity. Exp Neurol 274:134–144. https://doi.org/10.1016/j.expneurol.2015.09.010
Vecino E, Kwok JCF (2016) The extracellular matrix in the nervous system: the good and the bad aspects. In: Travascio F (ed) Composition and function of the extracellular matrix in the human body. InTech
Bukalo O, Schachner M, Dityatev A (2001) Modification of extracellular matrix by enzymatic removal of chondroitin sulfate and by lack of tenascin-R differentially affects several forms of synaptic plasticity in the hippocampus. Neuroscience 104:359–369. https://doi.org/10.1016/S0306-4522(01)00082-3
Saghatelyan AK, Dityatev A, Schmidt S et al (2001) Reduced perisomatic inhibition, increased excitatory transmission, and impaired long-term potentiation in mice deficient for the extracellular matrix glycoprotein tenascin-R. Mol Cell Neurosci 17:226–240. https://doi.org/10.1006/MCNE.2000.0922
Freitag S, Schachner M, Morellini F (2003) Behavioral alterations in mice deficient for the extracellular matrix glycoprotein tenascin-R. Behav Brain Res 145:189–207. https://doi.org/10.1016/S0166-4328(03)00109-8
Gurevicius K, Gureviciene I, Valjakka A et al (2004) Enhanced cortical and hippocampal neuronal excitability in mice deficient in the extracellular matrix glycoprotein tenascin-R. Mol Cell Neurosci 25:515–523. https://doi.org/10.1016/J.MCN.2003.12.001
Nikonenko A, Schmidt S, Skibo G et al (2003) Tenascin-R-deficient mice show structural alterations of symmetric perisomatic synapses in the CA1 region of the hippocampus. J Comp Neurol 456:338–349. https://doi.org/10.1002/cne.10537
Ferhat L, Chevassus Au Louis N, Jorquera I et al (1996) Transient increase of tenascin-C in immature hippocampus: Astroglial and neuronal expression. J Neurocytol 25:53–66. https://doi.org/10.1007/BF02284785
Nakic M, Manahan-Vaughan D, Reymann KG, Schachner M (1998) Long-term potentiation in vivo increases rat hippocampal tenascin-C expression. J Neurobiol 37:393–404. https://doi.org/10.1002/(SICI)1097-4695(19981115)37:3%3c393:AID-NEU5%3e3.0.CO;2-9
Morellini F, Malyshev A, Volgushev M et al (2017) Impaired fear extinction due to a deficit in Ca2+ influx through L-type voltage-gated Ca2+ channels in mice deficient for tenascin-C. Front Integr Neurosci 11:16. https://doi.org/10.3389/fnint.2017.00016
Schweitzer B, Singh J, Fejtova A et al (2017) Hyaluronic acid based extracellular matrix regulates surface expression of GluN2B containing NMDA receptors. Sci Rep 7:10991. https://doi.org/10.1038/s41598-017-07003-3
Kochlamazashvili G, Henneberger C, Bukalo O et al (2010) The extracellular matrix molecule hyaluronic acid regulates hippocampal synaptic plasticity by modulating postsynaptic L-type Ca2+ channels. Neuron 67:116–128. https://doi.org/10.1016/j.neuron.2010.05.030
Arancibia-Carcamo IL, Attwell D (2014) The node of Ranvier in CNS pathology. Acta Neuropathol 128:161–175
Susuki K, Chang K-J, Zollinger DR et al (2013) Three mechanisms assemble central nervous system nodes of Ranvier. Neuron 78:469–482. https://doi.org/10.1016/j.neuron.2013.03.005
Susuki K, Rasband MN (2008) Molecular mechanisms of node of Ranvier formation. Curr Opin Cell Biol 20:616–623. https://doi.org/10.1016/j.ceb.2008.09.007
Faivre-Sarrailh C, Devaux JJ (2013) Neuro-glial interactions at the nodes of Ranvier: implication in health and diseases. Front Cell Neurosci. https://doi.org/10.3389/fncel.2013.00196
Oohashi T, Hirakawa S, Bekku Y et al (2002) Bral1, a brain-specific link protein, colocalizing with the versican V2 isoform at the nodes of Ranvier in developing and adult mouse central nervous systems. Mol Cell Neurosci 19:43–57. https://doi.org/10.1006/mcne.2001.1061
Fields RD (2015) A new mechanism of nervous system plasticity: activity-dependent myelination. Nat Rev Neurosci 16:756–767
Löffek S, Schilling O, Franzke C-W (2011) Biological role of matrix metalloproteinases: a critical balance. Eur Respir J 38:191–208. https://doi.org/10.1183/09031936.00146510
Lu P, Takai K, Weaver VM, Werb Z (2011) Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb Perspect Biol 3:a005058. https://doi.org/10.1101/cshperspect.a005058
Nagy V (2006) Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory. J Neurosci 26:1923–1934. https://doi.org/10.1523/JNEUROSCI.4359-05.2006
Tsilibary E, Tzinia A, Radenovic L et al (2014) Neural ECM proteases in learning and synaptic plasticity, 1st edn. Elsevier B.V, Amsterdam
Bilousova TV, Dansie L, Ngo M et al (2008) Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model. J Med Genet 46:94–102. https://doi.org/10.1136/jmg.2008.061796
Michaluk P, Wawrzyniak M, Alot P et al (2011) Influence of matrix metalloproteinase MMP-9 on dendritic spine morphology. J Cell Sci 124:3369–3380. https://doi.org/10.1242/jcs.090852
Szepesi Z, Hosy E, Ruszczycki B et al (2014) Synaptically released matrix metalloproteinase activity in control of structural plasticity and the cell surface distribution of GluA1-AMPA receptors. PLoS One 9:e98274. https://doi.org/10.1371/journal.pone.0098274
Wang X, Bozdagi O, Nikitczuk JS et al (2008) Extracellular proteolysis by matrix metalloproteinase-9 drives dendritic spine enlargement and long-term potentiation coordinately. Proc Natl Acad Sci 105:19520–19525. https://doi.org/10.1073/pnas.0807248105
Okulski P, Jay TM, Jaworski J et al (2007) TIMP-1 abolishes MMP-9-dependent long-lasting long-term potentiation in the prefrontal cortex. Biol Psychiatry 62:359–362. https://doi.org/10.1016/j.biopsych.2006.09.012
Niedringhaus M, Chen X, Dzakpasu R, Conant K (2012) MMPs and soluble ICAM-5 increase neuronal excitability within in vitro networks of hippocampal neurons. PLoS One 7:e42631. https://doi.org/10.1371/journal.pone.0042631
Szepesi Z, Bijata M, Ruszczycki B et al (2013) Matrix metalloproteinases regulate the formation of dendritic spine head protrusions during chemically induced long-term potentiation. PLoS One 8:e63314. https://doi.org/10.1371/journal.pone.0063314
Lonskaya I, Partridge J, Lalchandani RR et al (2013) Soluble ICAM-5, a product of activity dependent proteolysis, increases mEPSC frequency and dendritic expression of GluA1. PLoS One 8:e69136. https://doi.org/10.1371/journal.pone.0069136
Nedivi E, Hevroni D, Naot D et al (1993) Numerous candidate plasticity-related genes revealed by differential cDNA cloning. Nature 363:718–722. https://doi.org/10.1038/363718a0
Cao W, Duan J, Wang X et al (2014) Early enriched environment induces an increased conversion of proBDNF to BDNF in the adult rat’s hippocampus. Behav Brain Res 265:76–83. https://doi.org/10.1016/j.bbr.2014.02.022
Bayat M, Sharifi MD, Haghani M, Shabani M (2015) Enriched environment improves synaptic plasticity and cognitive deficiency in chronic cerebral hypoperfused rats. Brain Res Bull 119:34–40. https://doi.org/10.1016/j.brainresbull.2015.10.001
Rivera S, Tremblay E, Timsit S et al (1997) Tissue inhibitor of metalloproteinases-1 (TIMP-1) is differentially induced in neurons and astrocytes after seizures: evidence for developmental, immediate early gene, and lesion response. J Neurosci 17:4223–4235
Jaworski J, Biedermann IW, Lapinska J et al (1999) Neuronal excitation-driven and AP-1-dependent activation of tissue inhibitor of metalloproteinases-1 gene expression in rodent hippocampus. J Biol Chem 274:28106–28112. https://doi.org/10.1074/jbc.274.40.28106
Knapska E, Lioudyno V, Kiryk A et al (2013) Reward learning requires activity of matrix metalloproteinase-9 in the central amygdala. J Neurosci 33:14591–14600. https://doi.org/10.1523/JNEUROSCI.5239-12.2013
Brown TE, Forquer MR, Cocking DL et al (2007) Role of matrix metalloproteinases in the acquisition and reconsolidation of cocaine-induced conditioned place preference. Learn Mem 14:214–223. https://doi.org/10.1101/lm.476207
Wilczynski GM, Konopacki FA, Wilczek E et al (2008) Important role of matrix metalloproteinase 9 in epileptogenesis. J Cell Biol 180:1021–1035. https://doi.org/10.1083/jcb.200708213
Meighan SE, Meighan PC, Choudhury P et al (2006) Effects of extracellular matrix-degrading proteases matrix metalloproteinases 3 and 9 on spatial learning and synaptic plasticity. J Neurochem 96:1227–1241. https://doi.org/10.1111/j.1471-4159.2005.03565.x
Kaliszewska A, Bijata M, Kaczmarek L, Kossut M (2012) Experience-dependent plasticity of the barrel cortex in mice observed with 2-DG brain mapping and c-Fos: effects of MMP-9 KO. Cereb Cortex 22:2160–2170. https://doi.org/10.1093/cercor/bhr303
Spolidoro M, Putignano E, Munaf C et al (2012) Inhibition of matrix metalloproteinases prevents the potentiation of nondeprived-eye responses after monocular deprivation in juvenile rats. Cereb Cortex 22:725–734. https://doi.org/10.1093/cercor/bhr158
Gorkiewicz T, Balcerzyk M, Kaczmarek L, Knapska E (2015) Matrix metalloproteinase 9 (MMP-9) is indispensable for long term potentiation in the central and basal but not in the lateral nucleus of the amygdala. Front Cell Neurosci 9:73. https://doi.org/10.3389/fncel.2015.00073
Kaczmarek L, Lapinska-Dzwonek J, Szymczak S (2002) Matrix metalloproteinases in the adult brain physiology: a link between c-Fos, AP-1 and remodeling of neuronal connections? EMBO J 21:6643–6648
Ganguly K, Rejmak E, Mikosz M et al (2013) Matrix metalloproteinase (MMP) 9 transcription in mouse brain induced by fear learning. J Biol Chem 288:20978–20991. https://doi.org/10.1074/jbc.M113.457903
Dziembowska M, Milek J, Janusz A et al (2012) Activity-dependent local translation of matrix metalloproteinase-9. J Neurosci 32:14538–14547. https://doi.org/10.1523/JNEUROSCI.6028-11.2012
Janusz A, Milek J, Perycz M et al (2013) The fragile X mental retardation protein regulates matrix metalloproteinase 9 mRNA at synapses. J Neurosci 33:18234–18241. https://doi.org/10.1523/JNEUROSCI.2207-13.2013
Nagaoka A, Takehara H, Hayashi-Takagi A et al (2016) Abnormal intrinsic dynamics of dendritic spines in a fragile X syndrome mouse model in vivo. Sci Rep 6:26651. https://doi.org/10.1038/srep26651
Gantois I, Khoutorsky A, Popic J et al (2017) Metformin ameliorates core deficits in a mouse model of fragile X syndrome. Nat Med 23:674–677. https://doi.org/10.1038/nm.4335
Conant K, Wang Y, Szklarczyk A et al (2010) Matrix metalloproteinase-dependent shedding of intercellular adhesion molecule-5 occurs with long-term potentiation. Neuroscience 166:508–521. https://doi.org/10.1016/j.neuroscience.2009.12.061
Michaluk P, Mikasova L, Groc L et al (2009) Matrix metalloproteinase-9 controls NMDA receptor surface diffusion through integrin _1 signaling. J Neurosci 29:6007–6012. https://doi.org/10.1523/JNEUROSCI.5346-08.2009
Michaluk P, Kaczmarek L (2007) Matrix metalloproteinase-9 in glutamate-dependent adult brain function and dysfunction. Cell Death Differ 14:1255–1258
Tian L, Stefanidakis M, Ning L et al (2007) Activation of NMDA receptors promotes dendritic spine development through MMP-mediated ICAM-5 cleavage. J Cell Biol 178:687–700. https://doi.org/10.1083/jcb.200612097
Lu B, Nagappan G, Lu Y (2015) BDNF and synaptic plasticity, cognitive function, and dysfunction. Handb Exp Pharmacol 220:223–250. https://doi.org/10.1007/978-3-642-45106-5_9
Gawlak M, Górkiewicz T, Gorlewicz A et al (2009) High resolution in situ zymography reveals matrix metalloproteinase activity at glutamatergic synapses. Neuroscience 158:167–176. https://doi.org/10.1016/j.neuroscience.2008.05.045
Konopacki FA, Rylski M, Wilczek E et al (2007) Synaptic localization of seizure-induced matrix metalloproteinase-9 mRNA. Neuroscience 150:31–39. https://doi.org/10.1016/j.neuroscience.2007.08.026
Sbai O, Ferhat L, Bernard A et al (2008) Vesicular trafficking and secretion of matrix metalloproteinases-2, -9 and tissue inhibitor of metalloproteinases-1 in neuronal cells. Mol Cell Neurosci 39:549–568. https://doi.org/10.1016/J.MCN.2008.08.004
Ogata Y, Enghild JJ, Nagase H (1992) Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem 267:3581–3584. https://doi.org/10.1108/20423891211271728
Ethell IM, Ethell DW (2007) Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets. J Neurosci Res 85:2813–2823. https://doi.org/10.1002/jnr
Overall CM (2002) Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites. Mol Biotechnol 22:051–086. https://doi.org/10.1385/MB:22:1:051
Cua RC, Lau LW, Keough MB et al (2013) Overcoming neurite-inhibitory chondroitin sulfate proteoglycans in the astrocyte matrix. Glia 61:972–984. https://doi.org/10.1002/glia.22489
Yuan W, Matthews RT, Sandy JD, Gottschall PE (2002) Association between protease-specific proteolytic cleavage of brevican and synaptic loss in the dentate gyrus of kainate-treated rats. Neuroscience 114:1091–1101. https://doi.org/10.1016/S0306-4522(02)00347-0
Tauchi R, Imagama S, Natori T et al (2012) The endogenous proteoglycan-degrading enzyme ADAMTS-4 promotes functional recovery after spinal cord injury. J Neuroinflammation 9:53. https://doi.org/10.1186/1742-2094-9-53
Hamel MG, Ajmo JM, Leonardo CC et al (2008) Multimodal signaling by the ADAMTSs (a disintegrin and metalloproteinase with thrombospondin motifs) promotes neurite extension. Exp Neurol 210:428–440. https://doi.org/10.1016/j.expneurol.2007.11.014
Howell MD, Torres-Collado AX, Iruela-Arispe ML, Gottschall PE (2012) Selective decline of synaptic protein levels in the frontal cortex of cemale mice deficient in the extracellular metalloproteinase ADAMTS1. PLoS One 7:e47226. https://doi.org/10.1371/journal.pone.0047226
Calabresi P, Napolitano M, Centonze D et al (2000) Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory. Eur J Neurosci 12:1002–1012. https://doi.org/10.1046/j.1460-9568.2000.00991.x
Huang YY, Bach ME, Lipp HP et al (1996) Mice lacking the gene encoding tissue-type plasminogen activator show a selective interference with late-phase long-term potentiation in both Schaffer collateral and mossy fiber pathways. Proc Natl Acad Sci 93:8699–8704. https://doi.org/10.1073/pnas.93.16.8699
Samson AL, Medcalf RL (2006) Tissue-type plasminogen activator: a multifaceted modulator of neurotransmission and synaptic plasticity. Neuron 50:673–678. https://doi.org/10.1016/j.neuron.2006.04.013
Qian Z, Gilbert ME, Colicos MA et al (1993) Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation. Nature 361:453–457. https://doi.org/10.1038/361453a0
Norris EH, Strickland S (2007) Modulation of NR2B-regulated contextual fear in the hippocampus by the tissue plasminogen activator system. Proc Natl Acad Sci 104:13473–13478. https://doi.org/10.1002/asna.18440211403
Pawlak R, Nagai N, Urano T et al (2002) Rapid, specific and active site-catalyzed effect of tissue-plasminogen activator on hippocampus-dependent learning in mice. Neuroscience 113:995–1001. https://doi.org/10.1016/S0306-4522(02)00166-5
Seeds NW, Basham ME, Haffke SP (1999) Neuronal migration is retarded in mice lacking the tissue plasminogen activator gene. Proc Natl Acad Sci 96:14118–14123
Frey U, Müller M, Kuhl D (1996) A different form of long-lasting potentiation revealed in tissue plasminogen activator mutant mice. J Neurosci 16:2057–2063
Madani R, Hulo S, Toni N et al (1999) Enhanced hippocampal long-term potentiation and learning by increased neuronal expression of tissue-type plasminogen activator in transgenic mice. EMBO J 18:3007–3012. https://doi.org/10.1093/emboj/18.11.3007
Zhuo M, Holtzman DM, Li Y et al (2000) Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation. J Neurosci 20:542–549
Pang PT, Teng HK, Zaitsev E et al (2004) Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 306(80):487–491. https://doi.org/10.1126/science.1100135
Tirosh O, Schwartz B, Zusman I et al (2004) Long-lived αMUPA transgenic mice exhibit increased mitochondrion-mediated apoptotic capacity. Ann N Y Acad Sci 1019:439–442. https://doi.org/10.1196/annals.1297.080
Miskin R, Masos T (1997) Transgenic mice overexpressing urokinase-type plasminogen activator in the brain exhibit reduced food consumption, body weight and size, and increased longevity. J Gerontol Ser A Biol Sci Med Sci 52:B118–B124. https://doi.org/10.1093/gerona/52A.2.B118
Meiri N, Masos T, Rosenblum K et al (1994) Overexpression of urokinase-type plasminogen activator in transgenic mice is correlated with impaired learning. Proc Natl Acad Sci USA 91:3196–3200
Rivera S, Khrestchatisky M, Kaczmarek L et al (2010) Metzincin proteases and their inhibitors: foes or friends in nervous system physiology? J Neurosci 30:15337–15357. https://doi.org/10.1523/JNEUROSCI.3467-10.2010
Baranger K, Rivera S, Liechti FD, Grandgirard D, Bigas J, Seco J, Tarrago T, Leib SL, Khrestchatisky M (2014) Endogenous and synthetic MMP inhibitors in CNS physiopathology. In: Prog Brain Res 214:313–351
Agrawal S, Lau L, Yong V (2008) MMPs in the central nervous system: where the good guys go bad. Semin Cell Dev Biol 19:42–51. https://doi.org/10.1016/j.semcdb.2007.06.003
Hewson AK, Smith T, Leonard JP, Cuzner ML (1995) Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790. Inflamm Res 44:345–349. https://doi.org/10.1007/BF01796266
Brundula V, Rewcastle NB, Metz LM et al (2002) Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis. Brain 125:1297–1308. https://doi.org/10.1093/BRAIN/AWF133
Rempe RG, Hartz AMS, Bauer B (2016) Matrix metalloproteinases in the brain and blood-brain barrier: versatile breakers and makers. J Cereb Blood Flow Metab 36:1481–1507. https://doi.org/10.1177/0271678X16655551
Suzuki Y, Nagai N, Umemura K et al (2007) Stromelysin-1 (MMP-3) is critical for intracranial bleeding after t-PA treatment of stroke in mice. J Thromb Haemost 5:1732–1739. https://doi.org/10.1111/j.1538-7836.2007.02628.x
Sumii T, Lo EH (2002) Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats. Stroke 33:831–836
Testero SA, Lee M, Staran RT et al (2011) Sulfonate-containing thiiranes as selective gelatinase inhibitors. ACS Med Chem Lett 2:177–181. https://doi.org/10.1021/ml100254e
Gu Z, Cui J, Brown S et al (2005) A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia. J Neurosci 25:6401–6408. https://doi.org/10.1523/JNEUROSCI.1563-05.2005
Cui J, Chen S, Zhang C et al (2012) Inhibition of MMP-9 by a selective gelatinase inhibitor protects neurovasculature from embolic focal cerebral ischemia. Mol Neurodegener 7:21. https://doi.org/10.1186/1750-1326-7-21
Zhao B-Q, Wang S, Kim H-Y et al (2006) Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med 12:441–445. https://doi.org/10.1038/nm1387
Fagan SC, Waller JL, Nichols FT et al (2010) Minocycline to improve neurologic outcome in stroke (MINOS). Stroke 41:2283–2287. https://doi.org/10.1161/STROKEAHA.110.582601
Minagar A, Alexander JS, Schwendimann RN et al (2008) Combination therapy with interferon beta-1a and doxycycline in multiple sclerosis. Arch Neurol 65:199–204. https://doi.org/10.1001/archneurol.2007.41
Groves MD, Puduvalli VK, Conrad CA et al (2006) Phase II trial of temozolomide plus marimastat for recurrent anaplastic gliomas: a relationship among efficacy, joint toxicity and anticonvulsant status. J Neurooncol 80:83–90. https://doi.org/10.1007/s11060-006-9160-y
Groves MD, Puduvalli VK, Hess KR et al (2002) Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme. J Clin Oncol 20:1383–1388. https://doi.org/10.1200/JCO.2002.20.5.1383
Prinomastat plus temozolomide following radiation therapy in treating patients with newly diagnosed glioblastoma multiforme—full text view—ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00004200. Accessed 8 Apr 2019
Rudek MA, New P, Mikkelsen T et al (2011) Phase I and pharmacokinetic study of COL-3 in patients with recurrent high-grade gliomas. J Neurooncol 105:375–381. https://doi.org/10.1007/s11060-011-0602-9
Vandenbroucke RE, Libert C (2014) Is there new hope for therapeutic matrix metalloproteinase inhibition? Nat Rev Drug Discov 13:904–927. https://doi.org/10.1038/nrd4390
Gantois I, Khoutorsky A, Popic J et al (2017) Metformin ameliorates core deficits in a mouse model of fragile X syndrome. Nat Med 23:674–677. https://doi.org/10.1038/nm.4335
Combined treatment of minocycline and lovastatin to treat individuals with fragile × syndrome—full text view—ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02680379. Accessed 8 Apr 2019
Levin M, Udi Y, Solomonov I, Sagi I (2017) Next generation matrix metalloproteinase inhibitors—novel strategies bring new prospects. Biochim Biophys Acta Mol Cell Res 1864:1927–1939. https://doi.org/10.1016/j.bbamcr.2017.06.009
Pantazopoulos H, Berretta S (2016) In sickness and in health: perineuronal nets and synaptic plasticity in psychiatric disorders. Neural Plast. 2016:9847696
Suttkus A, Rohn S, Weigel S et al (2014) Aggrecan, link protein and tenascin-R are essential components of the perineuronal net to protect neurons against iron-induced oxidative stress. Cell Death Dis 5:e1119. https://doi.org/10.1038/cddis.2014.25
Morawski M, Dityatev A, Hartlage-Rübsamen M et al (2014) Tenascin-R promotes assembly of the extracellular matrix of perineuronal nets via clustering of aggrecan. Philos Trans R Soc B Biol Sci 369:20140046. https://doi.org/10.1098/rstb.2014.0046
Vitellaro-Zuccarello L, Bosisio P, Mazzetti S et al (2007) Differential expression of several molecules of the extracellular matrix in functionally and developmentally distinct regions of rat spinal cord. Cell Tissue Res 327:433–447. https://doi.org/10.1007/s00441-006-0289-y
Matthews RT, Kelly GM, Zerillo CA et al (2002) Aggrecan glycoforms contribute to the molecular heterogeneity of perineuronal nets. J Neurosci 22:7536–7547
Mohan V, Talmi-Frank D, Arkadash V, Papo NSI (2016) Matrix metalloproteinase protein inhibitors: highlighting a new beginning for metalloproteinases in medicine. Met Med 3:31–47. https://doi.org/10.2147/MNM.S119588
Acknowledgements
Irit Sagi is an Incumbent of the Maurizio Pontecorvo Professorial Chair and has received funding from the Israeli Science Foundation (1226/13), the European Research Council AdG (THZCALORIMETRY—DLV-695437), and the USA-Israel Binational Science Foundation (712506-01). She is grateful for the Azrieli Foundation for its generous grant to conduct research on the extracellular matrix of the brain.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Krishnaswamy, V.R., Benbenishty, A., Blinder, P. et al. Demystifying the extracellular matrix and its proteolytic remodeling in the brain: structural and functional insights. Cell. Mol. Life Sci. 76, 3229–3248 (2019). https://doi.org/10.1007/s00018-019-03182-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-019-03182-6